Gryphon Financial Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $240K | Buy |
|
|||||
|
2025
Q2 | $215K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $218K | Sell |
|
|||||
|
2024
Q3 | $285K | Sell |
|
|||||
|
2024
Q2 | $433K | Sell |
|
|||||
|
2024
Q1 | $491K | Sell |
|
|||||
|
2023
Q4 | $681K | Buy |
|
|||||
|
2023
Q3 | $329K | Buy |
|
|||||
|
2023
Q2 | $125K | Sell |
|
|||||
|
2023
Q1 | $409K | Buy |
|
|||||
|
2022
Q4 | $368K | Buy |
|
|||||
|
2022
Q3 | $395K | Sell |
|
|||||
|
2022
Q2 | $470K | Buy |
|
|||||
|
2022
Q1 | $538K | Sell |
|
|||||
|
2021
Q4 | $684K | Sell |
|
|||||
|
2021
Q3 | $643K | Sell |
|
|||||
|
2021
Q2 | $520K | Buy |
|
|||||
|
2021
Q1 | $512K | Sell |
|
|||||
|
2020
Q4 | $561K | Sell |
|
|||||
|
2020
Q3 | $492K | Sell |
|
|||||
|
2020
Q2 | $428K | Sell |
|
|||||
|
2020
Q1 | $491K | Sell |
|
|||||
|
2019
Q4 | $653K | Buy |
|
|||||
|
2019
Q3 | $611K | Sell |
|
|||||
|
2019
Q2 | $524K | Sell |
|
|||||
|
2019
Q1 | $550K | Hold |
|
|||||
|
2018
Q4 | $440K | Sell |
|
|||||
|
2018
Q3 | $509K | Buy |
|
|||||
|
2018
Q2 | $34K | Hold |
|
|||||
|
2018
Q1 | $32K | Sell |
|
|||||
|
2017
Q4 | $27K | Buy |
|